1.
Opoku YK, Liu Z, Afrifa J, Kumi AK, Liu H, Ghartey-Kwansah G, et al. Fibroblast Growth Factor–21 ameliorates hepatic encephalopathy by activating the STAT3-SOCS3 pathway to inhibit activated hepatic stellate cells. EXCLI J. [Internet]. 2020 May 4 [cited 2024 Apr. 18];19:567-81. Available from: https://www.excli.de/index.php/excli/article/view/2232